Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. New York Presbyterian Hospital-Columbia University Med. Ctr.
FDA Inspection
•New York Presbyterian Hospital-Columbia University Med. Ctr.•November 28, 2023

New York Presbyterian Hospital-Columbia University Med. Ctr. – FDA Inspection, Nov 28, 2023

Record Details

This FDA Inspection record concerns New York Presbyterian Hospital-Columbia University Med. Ctr., with an inspection on November 28, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company
New York Presbyterian Hospital-Columbia University Med. Ctr.
Inspection Date
November 28, 2023
Product Type
Biologics
Office
Center for Biologics Evaluation and Research
Person
  • Irina Gaberman (FDA Associated Person)
View Company Profile

ID · 553ef8a6-8049-4b1b-8ea1-255f40c71415

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1223803
FDA center
Biologics
Project area
Blood and Blood Products
Outcome
Form 483 issued

FDA Citations

8
  1. 21 CFR 606.60(a)Equipment observed, standardized, calibrated
  2. 21 CFR 606.160(b)Required records
  3. 21 CFR 606.160(a)(1)Concurrent documentation
  4. 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
  5. 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
  6. 21 CFR 606.160(a)(1)Concurrent documentation
  7. 21 CFR 606.160(b)Required records
  8. 21 CFR 606.60(a)Equipment observed, standardized, calibrated

Full citation text and observation details available on the Dashboard.

Other FDA inspections of New York Presbyterian Hospital-Columbia University Med. Ctr.

7
DateClassificationOfficeProject area
July 2, 2026NAICenter for Biologics Evaluation and ResearchBlood and Blood Products
April 10, 2019NAICenter for Biologics Evaluation and ResearchBlood and Blood Products
April 6, 2017NAICenter for Biologics Evaluation and ResearchBlood and Blood Products
December 2, 2014VAICenter for Biologics Evaluation and ResearchBlood and Blood Products
January 29, 2013NAICenter for Biologics Evaluation and ResearchBlood and Blood Products
View all 7 other inspections on the company page
Other documents for New York Presbyterian Hospital-Columbia University Med. Ctr.
  • FDA Inspection 1325654 - 2026-07-02
  • FDA Inspection 1086853 - 2019-04-10
  • FDA Inspection 1006752 - 2017-04-06
  • FDA Inspection 905645 - 2014-12-02
  • FDA Inspection 816284 - 2013-01-29

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore New York Presbyterian Hospital-Columbia University Med. Ctr.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.